Scientists dive deep into VHL kidney tumors to unlock new clues
NCT ID NCT06195150
First seen May 16, 2026 · Last updated May 16, 2026
Summary
This study aims to understand how kidney tumors in people with von Hippel-Lindau (VHL) syndrome differ from one another and within the same tumor. Researchers will use advanced imaging, multiple biopsies, and lab-grown tumor models to map these differences. The goal is to gather knowledge that could guide future treatments, not to test a new therapy directly. Only 3 participants with VHL and at least 3 kidney tumors needing surgery are enrolled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLEAR CELL RENAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
IRCCS Ospedale San Raffaele
Milan, MI, 20132, Italy
Conditions
Explore the condition pages connected to this study.